www.verygoodnewsisrael.blogspot.com
Israel is approximately the size of New Jersey, but unlike our Garden State, threatened daily with terrorism and blood curdling threats and libels. Every day research and development in medicine, science, technology, agronomy, proceeds apace, enriching the lives of millions on every continent. Here is this week’s dazzling compilation from Michel Ordman. rsk
ISRAEL’S MEDICAL ACHIEVEMENTS
The next booster could be Israeli. The CEO of NRx – the US company in charge of trials of Israel’s BriLife coronavirus vaccine – said NRx is designing a Phase II study of BriLife as a booster to protect against COVID-19 variants. The study will be led by the research heads of Israel’s Hadassah and Sourasky (Ichilov) hospitals.
https://www.jns.org/israel-aims-to-test-brilife-vaccine-candidate-as-booster-dose/
92% recovery after 3 days. (TY Hazel) Israel’s Maccabi Healthcare has treated 850 of its high-risk coronavirus-infected customers with the new Pfizer Paxlovid pills. 60% significantly improved on the first day, rising to 92% within 3 days. All recovered. https://www.jpost.com/breaking-news/article-692757
Pancreatic cancer breakthrough. (TY UWI) Researchers at Tel Aviv’s Sourasky (Ichilov) Medical Center studied the data of 17,000 pancreatic cancer patients. They discovered that a mutation resulting in the absence of two proteins P15 and P16 allows the cancer to spread to the liver. The findings can help treat such patients.
https://www.israelhayom.com/2022/01/23/israeli-researchers-reveal-achilles-heel-of-pancreatic-cancer/
Non-invasive test for IBD. Israel’s Weizmann Institute, working together with Israel’s Sheba Medical Center can detect inflammation in the intestines by analyzing a fecal sample for the genes expressed in the cells. It can help diagnose gastric disorders such as Crohn’s disease and ulcerative colitis and monitor their treatment.
https://wis-wander.weizmann.ac.il/life-sciences/noninvasive-test-gut-inflammation
https://gut.bmj.com/content/early/2022/01/18/gutjnl-2021-325516?rss=1
https://www.israelnationalnews.com/news/320979
Look into my eyes. A great article about Israel’s Neurolight (see here previously) and its amazing ocular technology that extracts microscopic eye movement measurements to help diagnose neurological disorders. The platform aims to help developers of treatments for Parkinson’s, Alzheimer’s, and multiple sclerosis patients.
https://www.israel21c.org/the-answer-to-parkinsons-and-alzheimers-is-all-in-your-eyes/
AI management approved for type 2 diabetes. Israel’s DreaMed (see here previously) has now received US FDA approval for use with Type 2 diabetes sufferers as well as Type 1. It will relieve the strain on endocrinologist who each have on average some 46,000 patients.
https://www.timesofisrael.com/spotlight/israeli-startup-offers-hope-in-global-diabetes-crisis/
Israelis live longer. The latest report of life expectancy for Israeli men is 81 years – 8th in the OECD. For Israeli women it’s 84.8 – 11th in the OECD (see here for previous years). Both exceed the OECD average. Israel’s birth rate is by far the highest in the OECD and infant mortality is well below the OECD average.
https://www.jns.org/report-israelis-live-longer-lives-than-most-despite-major-deficits-in-health-care/